Abstract:Quant Imaging Med Surg 2021;11(2):870-875 | http://dx.doi.org/10.21037/qims-20-1253 In our recent study using a rat model of non-alcoholic fatty liver disease (NAFLD) induced with methionine and choline-deficient (MCD) diet, we demonstrated that collagen deposition in the liver strongly contribute to liver T1rho elongation, while fat deposition contributes to T1rho shortening (1,2). However, there were two questions remain unanswered. The first is that how the fat content’s contribution to T1rho shortening can be quantified. Secondly, since we estimated that 1% collagen area increase contributed to T1rho value increase of 1.35 ms, and this observation might have been damped by that fat deposition always co-existed with collagen deposition in this animal model, thus it remains undetermined that 1% collagen increase contributes to how much T1rho value elongation in the absence of liver steatosis. Hereby we try to address these two questions. Using last study’s data of each experimental rat’s collagen content (in percentage area measured with histology), MRI measured fat content (in percentage), and T1rho (in ms, millisecond), we ranked the results according to the collagen content and selected the 15 pairs where the collagen content difference within each pair was ≤0.03%. Since liver collagen content of experimental rats measured from 0.34– 6.46% (mean ± SD: 2.58%±1.54%), the within pair collagen content difference of these rats could be considered to be ‘zero’ (1). We took the assumption that, in our MCD model, inflammation’s contribution to T1rho per se was minimal, and was instead mediated via collagen deposition. Thus, leaving aside the issue of measurement imprecision, we can hypothesize that difference between each pair’s liver T1rho value was primarily due to the difference in liver fat content. Note we confirmed that liver fat content measured by MRI was almost the same as measured by histology (1). Figure 1A shows, when disregarding the amount of fat content difference, higher liver fat content is seen with longer liver T1rho value in 5 pairs while with shorter T1rho value in 10 pairs. The mean difference among the 15 pairs was −1.028 (95% confidence interval: −1.9499, −0.1061, P=0.031). The mean difference value of 10 pairs with T1rho shortening was three times of that of the 5 pairs with T1rho elongation (−1.874 vs. 0.664 ms). A mean of 8.72% higher fat content was associated with a mean of 1.03 ms T1rho shortening (data from Figure 1A). A linear regression suggests 10% fat increase contributed to 1.55 ms T1rho shortening (Figure 1B, Pearson r=−0.40). We hypothesize that higher Letter to the Editor

Liver injury monitoring, fibrosis staging and inflammation grading using T1rho magnetic resonance imaging: an experimental study in rats with carbon tetrachloride intoxication

MR T1ρ As an Imaging Biomarker for Monitoring Liver Injury Progression and Regression: an Experimental Study in Rats with Carbon Tetrachloride Intoxication.

T1rho Shortening Effect of Fat in Liver Steatosis after Fat Suppression: Approximate Estimation in a Methionine and Choline-Deficient (MCD) Diet Rat Model.

Collagen Deposition in the Liver is Strongly and Positively Associated with T1rho Elongation While Fat Deposition is Associated with T1rho Shortening: an Experimental Study of Methionine and Choline-Deficient (MCD) Diet Rat Model.

T1 Relaxation Times in the Rotating Frame for Assessing a Liver Injury-and-Recovery Animal Model

Comparison of T2, T1rho, and diffusion metrics in assessment of liver fibrosis in rats.

Staging Liver Fibrosis: Comparison of Native T1 Mapping, T2 Mapping, and T1ρ: an Experimental Study in Rats with Bile Duct Ligation and Carbon Tetrachloride at 11.7 T MRI

Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin αvβ3 for staging liver fibrosis in rat model

Assessment of Liver Fibrosis by Variable Flip Angle T-1 Mapping at 3.0T

Molecular Magnetic Resonance Imaging of Activated Hepatic Stellate Cells with Ultrasmall Superparamagnetic Iron Oxide Targeting Integrin αvβ3 for Staging Liver Fibrosis in Rat Model

Measurement of Liver T1 and T2 Relaxation Times in an Experimental Mouse Model of Liver Fibrosis

Impact of Liver Fibrosis and Fatty Liver on T1rho Measurements: A Prospective Study.

T1ρ magnetic resonance imaging for liver fibrosis detection and staging

Water Specific MRI T1 Mapping for Evaluating Liver Inflammation Activity Grades in Rats With Methionine‐Choline‐Deficient Diet‐Induced Nonalcoholic Fatty Liver Disease

Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Gd-Eob-Dtpa for the Evaluation of Liver Fibrosis Induced by Carbon Tetrachloride in Rats

Combining T1rho and advanced diffusion MRI for noninvasively staging liver fibrosis: an experimental study in rats

Assessment of Liver Fibrosis Using Pharmacokinetic Parameters of Dynamic Contrast-Enhanced Magnetic Resonance Imaging.

Assessment and integration of multiparametric MRI for liver fibrosis staging in rat non-alcoholic steatohepatitis: Evaluation of diagnostic efficiency and model interpretation

Diffusion Tensor Imaging of Liver Fibrosis in an Experimental Model

Assessing Liver Function by T1 Maps on Gd-EOB-DTPA-Enhanced MRI for up to 50 Min in Rat Models of Liver Fibrosis: A Longer Hepatobiliary Time Period may Help

The hepatocyte phase of Gd-EOB-DTPA-enhanced MRI in the evaluation of hepatic fibrosis and early liver cirrhosis in a rat model: An experimental study